Cargando…
The effect of disease severity markers on quality of life in autosomal dominant polycystic kidney disease: a systematic review, meta-analysis and meta-regression
BACKGROUND: Little is known about determinants of quality of life (QoL) in autosomal dominant polycystic kidney disease (ADPKD). Recent studies suggest that QoL in ADPKD is determined by more factors than mere renal function. We investigated the effect of ADPKD on QoL and evaluated how Qol is affect...
Autores principales: | Neijenhuis, Myrte K., Kievit, Wietske, Perrone, Ronald D., Sloan, Jeff A., Erwin, Patricia, Murad, Mohammad Hassan, Gevers, Tom J. G., Hogan, Marie C., Drenth, Joost P. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445294/ https://www.ncbi.nlm.nih.gov/pubmed/28545401 http://dx.doi.org/10.1186/s12882-017-0578-6 |
Ejemplares similares
-
Impact of liver volume on polycystic liver disease-related symptoms and quality of life
por: Neijenhuis, Myrte K, et al.
Publicado: (2017) -
Symptom relief and not cyst reduction determines treatment success in aspiration sclerotherapy of hepatic cysts
por: Neijenhuis, Myrte K., et al.
Publicado: (2018) -
Rationale and design of the RESOLVE trial: lanreotide as a volume reducing treatment for polycystic livers in patients with autosomal dominant polycystic kidney disease
por: Gevers, Tom JG, et al.
Publicado: (2012) -
Drug holiday in patients with polycystic liver disease treated with somatostatin analogues
por: van Aerts, René M. M., et al.
Publicado: (2018) -
Heterozygosity of ALG9 in Association with Autosomal Dominant Polycystic Liver Disease
por: Boerrigter, Melissa M., et al.
Publicado: (2023)